Nisa Investment Advisors’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.5K | Buy |
4,236
+3,921
| +1,245% | +$9.69K | ﹤0.01% | 2242 |
|
|
2025
Q1 | $627 | Sell |
315
-12,301
| -98% | -$24.5K | ﹤0.01% | 2753 |
|
|
2024
Q4 | $36.8K | Buy |
12,616
+12,507
| +11,474% | +$36.5K | ﹤0.01% | 1765 |
|
|
2024
Q3 | $422 | Sell |
109
-7,627
| -99% | -$29.5K | ﹤0.01% | 2750 |
|
|
2024
Q2 | $39.8K | Buy |
7,736
+7,702
| +22,653% | +$39.6K | ﹤0.01% | 1730 |
|
|
2024
Q1 | $238 | Buy |
34
+10
| +42% | +$70 | ﹤0.01% | 2612 |
|
|
2023
Q4 | $213 | Buy |
24
+4
| +20% | +$36 | ﹤0.01% | 2543 |
|
|
2023
Q3 | $191 | Sell |
20
-13
| -39% | -$124 | ﹤0.01% | 2673 |
|
|
2023
Q2 | $483 | Buy |
+33
| New | +$483 | ﹤0.01% | 2568 |
|